Cardio3 BioSciences Announces Participation At The 32nd Annual JP Morgan Healthcare Conference In San Francisco
12/30/2013 6:28:45 AM
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--December 30, 2013-- Regulatory News :
Cardio3 BioSciences (Paris:CARD) (Brussels:CARD) (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces its participation in the forthcoming Annual JP Morgan Healthcare Conference in San Francisco, on January 13 to 16, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by